- জেনেরিক নাম
- Glimepiride
- শক্তি
- 2 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Orion Pharma Ltd.
৳ ৪.৯৩ ৳ ৫.০৩ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Stimulin হলো Glimepiride-এর একটি ব্র্যান্ড, শক্তি ২ mg, ট্যাবলেট আকারে। দাম: প্রতি ইউনিট ৫.০৩ টাকা। Stimulin-এর সাথে Glimepiride-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Orion Pharma Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Glimepiride-এর ৪১টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১০টি। সবচেয়ে কম দাম Mepid 1 mg Tablet-এর, প্রতি ইউনিট ৳ ২.৫১।
Stimulin 2 mg is a tablet form of glimepiride, a medicine from the sulfonylurea group used for type 2 diabetes. It works by prompting the pancreas to release more insulin and by helping the body respond better to its own insulin. Doctors prescribe it alongside a proper diet and regular exercise when these measures alone do not keep blood sugar under control. It may also be combined with metformin in some patients. The dose and duration are set by the doctor based on regular blood sugar checks. The pack size is 3 x 10 tablets.
Stimulin is used to lower blood glucose in adults with non-insulin dependent (type 2) diabetes mellitus whose hyperglycaemia is not controlled by diet and exercise alone. It can be prescribed together with metformin when diet, exercise, and either glimepiride or metformin alone do not give adequate glycaemic control. It is not for type 1 diabetes, diabetic ketoacidosis, or diabetic coma. Your doctor will decide whether it suits your condition.
Take Stimulin exactly as your doctor instructs. The doctor decides the dose, how often to take it, and how long the course should last, adjusting it according to your blood sugar results. Regular monitoring of blood and urine glucose helps detect whether the treatment is working or failing. Never change the dose yourself. If you miss a dose, ask your doctor or pharmacist what to do. Swallow the tablet with water as advised.
Common side effects include hypoglycaemia (low blood sugar), temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, and a fall in blood pressure. Low blood sugar can cause symptoms such as sweating, shakiness, or confusion; if these occur, take glucose or sugar immediately and tell your doctor. Report any side effect to your doctor or pharmacist, especially if it is severe or persistent.
Before taking Stimulin, tell your doctor if you have liver or kidney problems, are on dialysis, or are allergic to glimepiride, other sulfonylureas, or sulfonamides. It is not suitable for type 1 diabetes, diabetic ketoacidosis, or diabetic coma. The risk of hypoglycaemia may be higher in the first weeks of treatment, so careful monitoring is needed. Do not take it during pregnancy or while breastfeeding; insulin is needed instead. Patients planning a pregnancy should inform their doctor. Ask your doctor or pharmacist about interactions with other medicines.
Stimulin is used for type 2 diabetes in adults when diet and exercise alone do not control blood sugar. It belongs to the sulfonylurea class of oral antidiabetic medicines and works by increasing insulin release from the pancreas. It is not for type 1 diabetes.
Take Stimulin only as your doctor prescribes. The doctor decides the dose, how often to take it, and how long the course lasts, based on your blood sugar checks. Do not change the dose yourself. Ask your doctor or pharmacist if you are unsure how to take it.
Glimepiride is the generic name of the active ingredient in Stimulin. It is a sulfonylurea antidiabetic medicine that lowers blood glucose by stimulating insulin release from pancreatic beta cells and by improving the body's response to insulin.
The listed price is ৳ ৫.০৩.
৳ ৪.৯৩ ৳ ৫.০৩ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is indicated in following conditions-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Do not store above 30°C. Keep away from light and out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।